跳至主要内容
临床试验/IRCT2015030820178N2
IRCT2015030820178N2已完成3 期

Comparison of Levofloxacin- containing and Clarithromycin -containing Sequential Therapies for Helicobacter pylori Eradication in Iran: A Randomized Clinical Trial

Iran University of Medical Sciences,Rasoul Akram Hospital,Colorectal Research Center0 个研究点目标入组 182 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
182

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • age more than18 years,patients with endoscopically confirmed peptic ulcer or gastric/duodenal erosions and H. pylori infection documentation by antral biopsy (Giemsa staining) and/or rapid urease test (RUT). exclusion criteria:pregnancy, breast-feeding, previous history of helicobacter pylori eradication,significant underlying diseases such as liver, cardiac, pulmonary or renal diseases, neoplasms, coagulopathy, history of gastric surgery, taking antibiotics,proton pump inhibior and /or histamin2 receptor antagonist during the previous2 weeks,concomitant use ofanticoagulant and/or corticosteroid, and previous
  • history of allergic reaction to any medications used in
  • this study.

排除标准

  • 未提供

研究者

发起方
Iran University of Medical Sciences,Rasoul Akram Hospital,Colorectal Research Center

相似试验